Page last updated: 2024-09-03

2'-deoxy-2'-methylenecytidine and Blood Diseases

2'-deoxy-2'-methylenecytidine has been researched along with Blood Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brindley, CJ; Devlin, AJ; Friberg, LE; Karlsson, MO1

Other Studies

1 other study(ies) available for 2'-deoxy-2'-methylenecytidine and Blood Diseases

ArticleYear
Models of schedule dependent haematological toxicity of 2'-deoxy-2'-methylidenecytidine (DMDC).
    European journal of clinical pharmacology, 2000, Volume: 56, Issue:8

    Topics: Antineoplastic Agents; Blood Platelets; Body Fluid Compartments; Carcinoma, Non-Small-Cell Lung; Cell Survival; Colorectal Neoplasms; Deoxycytidine; Drug Administration Schedule; Hematologic Diseases; Humans; Leukocyte Count; Leukocytes; Lung Neoplasms; Models, Biological; Neutropenia; Neutrophils; Platelet Count

2000